News & Events

News & Events

Latest

Hands of CDC scientist as they prepare to test a patient’s sample for SARS-CoV-2
Hands of CDC scientist as they prepare to test a patient’s sample for SARS-CoV-2
Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them
New England Journal of Medicine,

Biostatistics faculty members Tom Fleming and Betz Halloran sit on the WHO Ad Hoc Expert Group on the Next Steps for COVID-19 Vaccine Evaluation. In a recent New England Journal of Medicine article, the group notes that even though the efficacy of some COVID-19 vaccines appears to be high, reliable information will still be needed on longer-term safety and duration of protection.

6th Seattle Symposium Banner
6th Seattle Symposium Banner
UW Biostatistics students experience the 6th Seattle Symposium
Thanks to student support funding, 15 current students were able to attend keynote sessions, panel discussions and short courses offered through the 6th Seattle Symposium in Biostatistics: Precision Medicine in the Age of Data Science.
Jim Hughes
Jim Hughes
New HIV prevention treatment proves 89% more effective than current standard of care
Lead biostatistician Jim Hughes discusses study results and design challenges.
Witten and Gilbert
Witten and Gilbert
UW Biostatistics faculty among 2020 highly cited researchers
Two core faculty members from the University of Washington Department of Biostatistics in the School of Public Health have been recognized as
Word Aducanumab superimposed over graphic of human brain
Word Aducanumab superimposed over graphic of human brain
No Love for Aducanumab From FDA Advisers — Panel rejects mixed findings for controversial Alzheimer's drug
Medpage Today,

"This analysis seems to be subject to the Texas sharpshooter fallacy," where someone first fires a shot at a barn then paints a target around the bullet hole, said panelist and biostatistician Scott Emerson, MD, PhD, of the University of Washington in Seattle.